BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31265947)

  • 1. Anticancer Drug Response Prediction in Cell Lines Using Weighted Graph Regularized Matrix Factorization.
    Guan NN; Zhao Y; Wang CC; Li JQ; Chen X; Piao X
    Mol Ther Nucleic Acids; 2019 Sep; 17():164-174. PubMed ID: 31265947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved anticancer drug response prediction in cell lines using matrix factorization with similarity regularization.
    Wang L; Li X; Zhang L; Gao Q
    BMC Cancer; 2017 Aug; 17(1):513. PubMed ID: 28768489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting lncRNA-Protein Interaction With Weighted Graph-Regularized Matrix Factorization.
    Sun X; Cheng L; Liu J; Xie C; Yang J; Li F
    Front Genet; 2021; 12():690096. PubMed ID: 34335693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo Prediction of Cell-Drug Sensitivities Using Deep Learning-based Graph Regularized Matrix Factorization.
    Ren S; Tao Y; Yu K; Xue Y; Schwartz R; Lu X
    Pac Symp Biocomput; 2022; 27():278-289. PubMed ID: 34890156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A weighted non-negative matrix factorization approach to predict potential associations between drug and disease.
    Wang MN; Xie XJ; You ZH; Ding DW; Wong L
    J Transl Med; 2022 Dec; 20(1):552. PubMed ID: 36463215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graph regularized non-negative matrix factorization with prior knowledge consistency constraint for drug-target interactions prediction.
    Zhang J; Xie M
    BMC Bioinformatics; 2022 Dec; 23(1):564. PubMed ID: 36581822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graph regularized non-negative matrix factorization with [Formula: see text] norm regularization terms for drug-target interactions prediction.
    Zhang J; Xie M
    BMC Bioinformatics; 2023 Oct; 24(1):375. PubMed ID: 37789278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DSPLMF: A Method for Cancer Drug Sensitivity Prediction Using a Novel Regularization Approach in Logistic Matrix Factorization.
    Emdadi A; Eslahchi C
    Front Genet; 2020; 11():75. PubMed ID: 32174963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Microbe-Disease Association Prediction With Graph Regularized Non-Negative Matrix Factorization.
    He BS; Peng LH; Li Z
    Front Microbiol; 2018; 9():2560. PubMed ID: 30443240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving drug response prediction based on two-space graph convolution.
    Peng W; Chen T; Liu H; Dai W; Yu N; Lan W
    Comput Biol Med; 2023 May; 158():106859. PubMed ID: 37023539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining non-negative matrix factorization with graph Laplacian regularization for predicting drug-miRNA associations based on multi-source information fusion.
    Wang MN; Li Y; Lei LL; Ding DW; Xie XJ
    Front Pharmacol; 2023; 14():1132012. PubMed ID: 36817132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NeuPD-A Neural Network-Based Approach to Predict Antineoplastic Drug Response.
    Shahzad M; Tahir MA; Alhussein M; Mobin A; Shams Malick RA; Anwar MS
    Diagnostics (Basel); 2023 Jun; 13(12):. PubMed ID: 37370938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DeepDSC: A Deep Learning Method to Predict Drug Sensitivity of Cancer Cell Lines.
    Li M; Wang Y; Zheng R; Shi X; Li Y; Wu FX; Wang J
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):575-582. PubMed ID: 31150344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Improved Anticancer Drug-Response Prediction Based on an Ensemble Method Integrating Matrix Completion and Ridge Regression.
    Liu C; Wei D; Xiang J; Ren F; Huang L; Lang J; Tian G; Li Y; Yang J
    Mol Ther Nucleic Acids; 2020 Sep; 21():676-686. PubMed ID: 32759058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Target Interaction Prediction via Dual Laplacian Graph Regularized Logistic Matrix Factorization.
    Wang A; Wang M
    Biomed Res Int; 2021; 2021():5599263. PubMed ID: 33855072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical drug response prediction from preclinical cancer cell lines by logistic matrix factorization approach.
    Emdadi A; Eslahchi C
    J Bioinform Comput Biol; 2022 Apr; 20(2):2150035. PubMed ID: 34923927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative graph regularized matrix factorization for drug-pathway associations analysis.
    Dai LY; Zheng CH; Liu JX; Zhu R; Yuan SS; Wang J; Kong XZ
    Comput Biol Chem; 2019 Feb; 78():474-480. PubMed ID: 30581072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DBDNMF: A Dual Branch Deep Neural Matrix Factorization method for drug response prediction.
    Liu H; Wang F; Yu J; Pan Y; Gong C; Zhang L; Zhang L
    PLoS Comput Biol; 2024 Apr; 20(4):e1012012. PubMed ID: 38574114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L
    Cui Z; Gao YL; Liu JX; Dai LY; Yuan SS
    BMC Bioinformatics; 2019 Jun; 20(Suppl 8):287. PubMed ID: 31182006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Collaborative Weighted Non-negative Matrix Factorization Improves Prediction of Disease-Associated Human Microbes.
    Xu D; Xu H; Zhang Y; Gao R
    Front Microbiol; 2022; 13():834982. PubMed ID: 35369503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.